ISPOR 2022 recorded session

It's time to grab your customers attention properly. Let us help you.

Applying Advanced Real-World Evidence to HEOR: What, Why, and How?

The hour-long session is split into 5 sections:

Introduction by Dan Riskin, Verantos
Dr. Keri Monda, Executive Director, Center for Observational Research at Amgen, discusses the RWE journey Amgen has taken, including pitfalls and opportunities.
Dr. A. Reshad Garan, Director of Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease at Harvard’s Beth Israel Lahey, discusses their engagement in RWE and how it’s influencing care delivery.
Dr. Steve Kymes, Lundbeck's Director of Health Economics and Outcomes Research, discusses advanced real-world evidence efforts in migraine and how these approaches impact product launch.
Discussion

Learn more

Title

Lorem ipsum

Introduction

Click the thumbnail to watch each video. The audio may play for 12 seconds before the video starts.

Length: 2:29

Application of high-validity RWE in drug development:
A case study in asthma

Dr. Keri Monda, Executive Director, Center for Observational Research at Amgen, discusses the RWE journey Amgen has taken, including pitfalls and opportunities.

Length: 9:18

Using real-world evidence in heart failure

Dr. A. Reshad Garan, Director of Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease at Harvard’s Beth Israel Lahey, discusses his organization's engagement in RWE and how RWE is influencing care delivery.

Length: 8:44

Advanced RWE in a product launch

Dr. Steve Kymes, Lundbeck's Director of Health Economics and Outcomes Research, discusses advanced real-world evidence efforts in migraine and how these approaches impact product launch.

Length: 10:22

Discussion and Q&A

Length: 30:28